Monix

📍 Allschwil, Switzerland🗓 Founded 2024👥 6 employees💰 Last funded Dec 2025
Medical and Diagnostic Laboratories🌐 monix.health
Website LinkedIn
Monix is the world’s first real-time hormone health platform, powered by a wearable biosensor designed specifically for women. We provide continuous, non-invasive monitoring of female hormones — starting with IVF, and expanding into menopause, endocrinology and every stage of hormonal health. At the intersection of biosensing, AI, and women’s health, Monix makes what was once invisible, visible. By unlocking real-time hormone data, we empower women and clinicians with the insights they need to make better decisions — every day, every cycle. Our vision is bold: to become the hormonal health companion for every woman —across fertility, menopause, and lifelong hormonal wellness. We’re entrepreneurs, scientists, engineers, and doctors on a mission to close the gender data gap in medicine — one hormone at a time. Backed by science. Built for women. Powered by data.
2
Total investors
2
Early stage
0
Mid stage
0
Late stage
2024
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Denmark
2
Frequently asked questions
Who invested in Monix?
Monix has 2 investors on record on gritt.io, including 2 early-stage backers.
When did Monix last raise funding?
The most recent investment in Monix recorded on gritt.io was in December 2025.
When was Monix founded?
Monix was founded in 2024.
What industry is Monix in?
Monix operates in Medical and Diagnostic Laboratories. Find similar Medical and Diagnostic Laboratories investors on gritt.io.
Where is Monix based?
Monix is headquartered in Allschwil, Switzerland.